Navigation Links
Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc.
Date:1/15/2014

DUBLIN, January 15, 2014 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced tender offer for all of the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).  

As a result of the waiver, the transaction is no longer conditional on OFT approval, and Shire expects to complete the tender offer on January 24, 2014 following the currently scheduled expiration time, subject to the satisfaction of all of the remaining conditions to the tender offer.  The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) expired on December 10, 2013.  

The tender offer is scheduled to expire at midnight, New York City time, on Thursday, January 23, 2014 (one minute after 11:59 p.m., New York City time, on January 23, 2014).

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

http://www.shire.com


ADDITIONAL INFORMATION AND WHERE TO FIND IT  

This announcement is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell ViroPharma common stock. The offer to buy ViroPharma common stock is being made pursuant to a tender offer statement (including the offer to purchase, letter of transmittal and other related t
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
2. Shire Extends Tender Offer for ViroPharma
3. Shire Reports Top-Line Results on OPUS-2, a Phase 3 Study Investigating the Use of Lifitegrast (5.0% Ophthalmic Solution) in Adults With Dry Eye Disease
4. MinuteClinic Opens First Clinic Locations in New Hampshire
5. Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC.
6. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
7. Shire to Present at the Morgan Stanley Global Healthcare Conference
8. Shire Reports 7% Product Sales Growth: Anticipating Double Digit Non GAAP Earnings Growth in 2013
9. Shire Announces Award Recipients for 2013 US ADHD Scholarship Program
10. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
11. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Sept. 1, 2014 ... is available in its catalogue: Antibody ... http://www.reportlinker.com/p02280919/Antibody-Drug-Conjugates-Market-2nd-Edition-2014---2024.html ... new class of therapeutic agents, gaining increasing attention ... addressed as the marriage of an antibody with ...
(Date:8/30/2014)... --  Royal Philips  (NYSE: PHG, AEX: PHIA) today announced ... system designed to enable global hospitals and health systems ... cost pressures. Making its debut at the  European Society ... this week, Affiniti provides innovative technology to ... deliver high quality patient care. "Affiniti ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
Breaking Medicine Technology:Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2
(Date:9/2/2014)... 2 September 2014: Health structures explain nearly 20% ... to the results of a joint ESC-OECD study ... Maggioni. Clinical variables explained more than 80% of ... unique evaluation which combines clinical data and health ... fuller picture of the reasons some patients with ...
(Date:9/2/2014)... Developers and plugin specialist of Final Cut ... from Pixel Film Studios. , “ProIntro has enabled users ... Christina Austin, CEO of Pixel Film Studios. “Blurring the ... game changer.” , Learn how to create a title ... Studios. ProIntro is a package of professionally designed titles ...
(Date:9/2/2014)... NOVAtime Technology, Inc. ( http://www.novatime.com ... announced today that Avon Health Center, a long-time ... NOVAtime 4000 Time and Attendance / Workforce ... latest smart clock, the NT7000 . , Avon ... is an award-winning nursing facility that provides short-term ...
(Date:9/2/2014)... “Harmonicas have been formally used ... to help people with COPD or asthma. At ... systems,” says Dana Keller, PhD, co-inventor of the ... are much the same – improved health with ... harmonica.” , The three approaches to harmonicas in ...
(Date:9/2/2014)... September 02, 2014 September 2014 – The ... gone. But even though men shave daily – and commit ... rough and irritated skin isn’t inevitable, according to Joshua ... , For decades, skin care was something in which ... surge in men of all ages who realize that their ...
Breaking Medicine News(10 mins):Health News:Health structures explain nearly 20 percent of non-adherence to heart failure guidelines 2Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios Released a New ProIntro Lesson Exclusively for Final Cut Pro X 3Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3
... dengue fever in early stage was launched in India Monday ... distributor of life science research products and clinical diagnostics. ... to diagnose dengue on the first day of symptoms, the ... - the first in the Indian market - is based ...
... to be safer to use than laser surgery to correct ... being contested by a physician William Mathers, M.D from Health ... comparing data from many recent studies who feels the results ... ,Dr Mathers, Professor of Ophthalmology in the OHSU School ...
... have quit the NHS rather than sign new contracts. Around ... around one million patients without an NHS dentist. ... over the changes. If their issues are still not resolved, ... switch to private practice. ,Since the introduction of ...
... term schizophrenia should be done away with, as it has ... is a harmful concept," said Professor Marius Romme, a visiting ... in Birmingham.,He added, "Symptoms such as delusions, hearing voices and ... be reactions to traumatic and troubling events in life. " ...
... medicine regulators to begin selling its new breast cancer pill ... last month, and comes slightly earlier than some commentators were ... GSK's most promising pipeline drugs as well as a potential ... the drug could cross 2 bln used by 2010. ...
... patients before the surgical removal of the tumour, than ... 1 %. The usual treatment for bowel cancer ... and once reappeared, treatment is difficult and usually incurable. ... to compare the effect of radiotherapy before and after ...
Cached Medicine News:Health News:Laser Surgery Safer Than Contact Lenses? 2Health News:NHS Dentists Shortage worsens over New Contracts 2Health News:‘Schizophrenia’ term ought to be abolish 2
Mid-level interpretive resting ECG...
... The ECG-9010 meets IEC60601-2-51 new ... accuracy and digital filter performance. ECG ... on a Windows PC with the ... be changed for operating in other ...
The Sonic WAVE™is the first market-ready Alternative to Ultrasound...
... Critical Care Xpress is an innovative, stat ... and hematology with on-board co-oximetry and integrated ... instrument. Measured tests include pH, PCO 2 ... hematocrit and hemoglobin, sodium, potassium, chloride, ionized ...
Medicine Products: